Cargando…

Liposome Technology for Industrial Purposes

Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Andreas, Vorauer-Uhl, Karola
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065896/
https://www.ncbi.nlm.nih.gov/pubmed/21490754
http://dx.doi.org/10.1155/2011/591325
_version_ 1782201034844667904
author Wagner, Andreas
Vorauer-Uhl, Karola
author_facet Wagner, Andreas
Vorauer-Uhl, Karola
author_sort Wagner, Andreas
collection PubMed
description Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
format Text
id pubmed-3065896
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30658962011-04-13 Liposome Technology for Industrial Purposes Wagner, Andreas Vorauer-Uhl, Karola J Drug Deliv Review Article Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents. Hindawi Publishing Corporation 2011 2010-12-05 /pmc/articles/PMC3065896/ /pubmed/21490754 http://dx.doi.org/10.1155/2011/591325 Text en Copyright © 2011 A. Wagner and K. Vorauer-Uhl. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wagner, Andreas
Vorauer-Uhl, Karola
Liposome Technology for Industrial Purposes
title Liposome Technology for Industrial Purposes
title_full Liposome Technology for Industrial Purposes
title_fullStr Liposome Technology for Industrial Purposes
title_full_unstemmed Liposome Technology for Industrial Purposes
title_short Liposome Technology for Industrial Purposes
title_sort liposome technology for industrial purposes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065896/
https://www.ncbi.nlm.nih.gov/pubmed/21490754
http://dx.doi.org/10.1155/2011/591325
work_keys_str_mv AT wagnerandreas liposometechnologyforindustrialpurposes
AT voraueruhlkarola liposometechnologyforindustrialpurposes